CN Patent

CN111467301A — 使用伊维菌素治疗丘疹脓疱性红斑痤疮

Assigned to Galderma SA · Expires 2020-07-31 · 6y expired

What this patent protects

描述了安全有效治疗患者的丘疹脓疱性红斑痤疮的组合物和方法。所述方法包括对受影响皮肤区域局部施用外部的组合物，所述组合物包含伊维菌素和药学可接受的载体。相比于传统的疗法，使用伊维菌素的疗法代表着更稳健和有效的创新疗法。

USPTO Abstract

描述了安全有效治疗患者的丘疹脓疱性红斑痤疮的组合物和方法。所述方法包括对受影响皮肤区域局部施用外部的组合物，所述组合物包含伊维菌素和药学可接受的载体。相比于传统的疗法，使用伊维菌素的疗法代表着更稳健和有效的创新疗法。

Drugs covered by this patent

Patent Metadata

Patent number
CN111467301A
Jurisdiction
CN
Classification
—
Expires
2020-07-31
Drug substance claim
No
Drug product claim
No
Assignee
Galderma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.